EZL
Asset Logo

Euroz Hartleys Group Limited

🇦🇺 ASX

💸 FINANCIALS

Compare
Add to watchlist
👑 Overview

📈 Performance

💰 Dividends

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-3.56%
Annual Growth

5 years average annual growth

💰

5.52%
Annual dividend yield

Based on the most recent dividend

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Euroz Hartleys Group Ltd. engages in the business of financial solutions. The company is headquartered in Perth, Western Australia. The firm provides a range of financial services from stockbroking to corporate finance, investing, funds management and wealth management. The Company’s segments include private wealth, wholesale, funds management, and others. The private segment includes private wealth advisers who work with high net wealth individuals, companies, SMSF and other clients. The Private wealth advisers provide investment offering of stockbroking and corporate services for clients. The Wholesale segment refers to the institutional dealing, research and corporate finance team who work with companies and other institutional clients. The Fund Management segment offers funds management services. The company provides a range of corporate finance, stockbroking, wealth management, institutional sales and targeted research services. Its subsidiaries include Euroz Hartleys Limited and Westoz Funds Management Pty Ltd.

📈 Performance

Price History

-32.21%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💰 Dividends

Payouts

💰 Annual Dividend Yield*

5.52%

💰 Annual Dividend Earnings Per $1,000 invested**

$55.23

💰 Most Recent Dividend Franked Percentage Estimate

100.00%

💰 Average Dividend Franked Percentage Estimate

100.00 %

💰 Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Estimate your dividend

If you held

$

of EZL, your last dividend payment(s) would have been:

$ 478.85

on Fri Aug 30 2024

$ 280.9

on Fri Feb 16 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2024

$0.05

100.00%

2023

$0.06

100.00%

2022

$0.31

50.00%

2021

$0.16

100.00%

2020

$0.08

100.00%

2019

$0.07

100.00%

2018

$0.11

100.00%

2017

$0.07

100.00%

2016

$0.04

100.00%

2015

$0.05

50.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.83

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in EZL

0

📊 Total Capital Earnings

$5K

🔃 Average investment frequency

21 weeks

💵 Average investment amount

$5,024

Last time a customer invested in EZL

165 days
EZL investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in EZL also invest in...

BetaShares Global Robotics and Artificial Intelligence ETF

RBTZ

RBTZ.AX was created on 2018-09-12 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. RBTZ.AX aims to track the performance of an index (before fees and expenses) that includes global companies involved in the production or use of robotics and artificial intelligence (A.l.) products and services.

🙌 Performance (5Yr p.a)

7.37%

📊 Share price

$13.19 AUD

🤖 TECHNOLOGY

🇦🇺 EX AUSTRALIA

Find Out More

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).

🙌 Performance (5Yr p.a)

13.60%

📊 Share price

$80.02 AUD

🤖 TECHNOLOGY

🏭 INDUSTRIALS

🇦🇺 EX AUSTRALIA

📈 HIGH PRICE GROWTH

Arafura Rare Earths Ltd. engages in the exploration and development of mineral resource properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-11-05. The firm produces rare earth products from the Nolans Project. The Nolans Project consists of a mine, process plant, including beneficiation, extraction and separation plants, and related infrastructure to be constructed and located at the Nolans site, approximately 135 kilometers north of Alice Springs in Australia's Northern Territory. Its rare earth products are Neodymium-Praseodymium (NdPr) oxide, and Mixed middle-heavy rare earths (SEG/HRE) oxide. NdPr oxide is the Company's flagship product, which is used by magnet and magnet alloy customers. The Company’s primary products from the Nolans project are rare earths, which are used in catalytic converters in automobiles, consumer electronics, energy efficiency lighting, optics, alloys, advanced ceramics and permanent magnets that enable e-mobility and renewable energy applications.

🙌 Performance (5Yr p.a)

15.63%

📊 Share price

$0.15 AUD

📈 HIGH PRICE GROWTH

⛏️ MINING

Auroch Minerals Ltd. engages in the exploration of mineral properties. The firm's projects include the Saints Nickel project, Leinster Nickel project, Nepean Nickel project, Arden project, Bonaventura project and Torrens East Copper project. The company holds a nickel exploration portfolio with the Nepean, Saints and Leinster Projects all located within the Goldfields region of Western Australia. The Saints Nickel project is located approximately 65 kilometers (km) northwest of Kalgoorlie. The Leinster Nickel project is located approximately 40km southeast of Leinster. Nepean Nickel project is located approximately 60km southwest of Kalgoorlie. The Arden project is located approximately 315km north of Adelaide. Bonaventura project is on Northern Kangaroo Island, South Australia. Torrens East Copper project is located within the Torrens Hinge Zone of the Olympic Dam copper-gold province. The firm also has 80% interest in Nevada Lithium Project, located in Nevada.

📊 Share price

$0.07 AUD

HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.

🙌 Performance (5Yr p.a)

13.05%

📊 Share price

$11.65 AUD

📈 HIGH PRICE GROWTH

🤖 TECHNOLOGY

🇦🇺 EX AUSTRALIA

Want more shares? Try these...

EZZ Life Science Holdings Ltd. is a genomic life science company, which engages in the business of formulating, producing, marketing, and selling branded health and wellbeing products to retailers and consumers domestically and internationally. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is engaged in research and development in genomics and precision nutrition with a focus on four human health challenges, including genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company formulates, produces, markets and distributes health supplements under the brand of EZZ to retailers and consumers domestically and internationally. The firm is also a wholesale distributor of skin care products under the EAORON brand in Australia and New Zealand to pharmacies, supermarkets and specialist retailers. Its products under the EZZ brand include EZZ Hair Growth Spray, EZZ Hair Scrub, EZZ Hair Mask, EZZ Anti-frizz Hair Spray, EZZ Biotic Engastro Capsule, EZZ Coffee Jelly and EZZ Iron Jelly. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, herbal/ traditional and pediatric consumer health products.

📊 Share price

$3.12 AUD

🔭 LIFE SCIENCES TOOLS & SERVICES

F100.AX was created on 2019-07-12 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to track the price and income performance of the FTSE 100 Index (before fees and expenses). The Index provides exposure to the largest 100 comoanies traded on the London Stock Exchange, based on their market capitalisation.

🙌 Performance (5Yr p.a)

4.09%

📊 Share price

$12.31 AUD

⛳️ DIVERSIFIED

📊 Share price

$0.00 AUD

Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. The company is headquartered in Adelaide, South Australia. The firm operates through three segments: AlphaRET, and Glaucoma surgical devices. The Company’s AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pulse laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the designing, manufacturing, marketing, and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device. The Molteno3 glaucoma drainage device platform is designed to enhance surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma.

🙌 Performance (5Yr p.a)

-7.33%

📊 Share price

$0.18 AUD

🩺 HEALTH CARE

Compare
Add to watchlist